Harrow Health公司已重新推出Verkazia®（环孢素眼用乳剂）0.1%，专门用于治疗春季角结膜炎。这一举措旨在应对儿童眼科护理中长期存在的显著未满足需求，为患有这种严重过敏性眼病的儿童患者提供新的治疗方案。
Harrow Health公司已重新推出Verkazia®（环孢素眼用乳剂）0.1%，专门用于治疗春季角结膜炎。这一举措旨在应对儿童眼科护理中长期存在的显著未满足需求，为患有这种严重过敏性眼病的儿童患者提供新的治疗方案。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.